The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of Substitute Bill No.7118 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.
The Academy of Managed Care Pharmacy (AMCP) thanks the Washington Department of Labor & Industries for the opportunity to provide comments in response to CR-102 Proposed Language on Interchangeable Biologics, the Prescription Drug Program and Therapeutic Interchange.
In support of House Bill No. 628, AMCP believes that a pilot medication therapy management (MTM) program for patients in the TennCare program will lead to higher quality care for those patients.
The Academy of Managed Care Pharmacy (AMCP) urges you to support Senate Bill No. 398, which would establish a Medication Therapy Management (MTM) pilot program as a component of the TennCare program.
The Academy of Managed Care Pharmacy (AMCP) urges you to support House Bill No. 628, which would establish a Medication Therapy Management (MTM) pilot program as a component of the TennCare program. MTM services have demonstrated success for Medicare Part D beneficiaries by improving patient outcomes while decreasing overall health care costs, and AMCP strongly supports the expansion of MTM services for other patient groups including Medicaid beneficiaries.
The Academy of Managed Care Pharmacy (AMCP) thanks the Pharmacy Quality Alliance (PQA) for the opportunity to provide comments in response to the memo titled Endorsement Consideration by PQA Members of Three New Performance Measures.